About Barbara Wirostko
Barbara Wirostko is an executive officer at Qlaris Bio.
Barbara Wirostko first appears on SEC filings in 2019.
Experience
This experience comes from Barbara Wirostko's profile and from SEC filings. For roles taken from filings, the years are when the filings name Barbara Wirostko in the role, so the role may have started earlier or lasted longer.
AA
Association for Research in Vision and Ophthalmology (ARVO) Current
Chairperson of the Board
2026 – Present
MB
Montana State University-Bozeman Current
Montana State Hilleman Scholars Board Member
2026 – Present
MY
MyEyes Current
Co-Founder and Medical Advisor
2021 – Present
Qlaris Bio, Inc. Current
Co-Founder and Chief Medical Officer
2019 – Present · Dedham, MA
Develops glaucoma treatments for patients with the eye disease.
JF
Joseph James Morelli Legacy Foundation Current
Founder, President, and Executive Director
2014 – Present
CC
California Institute for Regenerative Medicine (CIRM) Current
Strategic Advisor and Grant Review Committee Member
2012 – Present
WP
Wirostko MD PC Current
Consultant
2010 – Present
UM
University of Utah School of Medicine Current
Clinical Adjunct Professor
2010 – Present
HI
Humonix Biosciences, Inc.
Board Member and Strategic Advisor
2015 – 2026
EI
EyeGate Pharmaceuticals, Inc.
Chief Medical Officer
2016 – 2019
JI
Jade Therapeutics Inc.
Co Founder and Chief Scientific Officer
2012 – 2016
AI
Altheos Inc
Chief Medical Officer
2010 – 2012
PF
Pfizer
Senior Medical Director
2006 – 2010
Key Colleagues at Startups
The people Barbara Wirostko works with at each company, as listed on that company's latest Form D.
Qlaris Bio, Inc. · Form D, Jun 17, 2026
AG
Adrienne Graves
Director
WH
Wende Hutton
Director
RW
Robert Warner
Director
FG
Frederic Guerard
President and Chief Executive Officer, director
RH
Ronald Hunt
Director
AD
Andrew Danielson
Director